BeStock  
Stocks › Biotechnology › VERA

Vera Therapeutics VERA

US equityMarket cap rank #2729Biotechnology
$25.45 −$1.30 (-4.86%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $24.88 -2.24%
Open$26.37
Prev close$26.75
Day range$25.16 – $27.15
Volume1.37M
Market cap$1.84B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-4.8x
CheapRich

Above its usual level · 78th percentile, 5-year average -8.8x

Price / book6.1x
CheapRich

Above its usual level · 69th percentile, 5-year average 6.0x

#4581 of 5330 stocks by PB (1 = cheapest)

Price / sales197.7x
CheapRich

Near the top of its 5-year range · 100th percentile, 5-year average 1.0x

#5006 of 5155 stocks by PS (1 = cheapest)

P/E over five years

-24x-16x-8x1xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$44.07
Price vs. fair value-42.2%Trading below the estimate
Star rating★★★★☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 6.10 – 5.98 69% (pricier than usual) #4581 of 5330 (1 = cheapest)
PE -4.76 -6.76 -8.79 78% (pricier than usual) –
PS 197.68 10.26 1.00 100% (pricier than usual) #5006 of 5155 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on VERA.

Sign in to join the discussion.

Scroll to Top